cyclolaudenol has been researched along with triparanol in 1 studies
*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]
*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raederstorff, D; Rohmer, M | 1 |
1 other study(ies) available for cyclolaudenol and triparanol
| Article | Year |
|---|---|
Polyterpenoids as cholesterol and tetrahymanol surrogates in the ciliate Tetrahymena pyriformis.
Topics: Animals; Cholesterol; Lanosterol; Phytosterols; Polymers; Sitosterols; Squalene; Tetrahymena pyriformis; Triparanol; Triterpenes | 1988 |